KR100533565B1 - 신규한 오당류, 이의 제조방법 및 이를 포함하는 제약 조성물 - Google Patents

신규한 오당류, 이의 제조방법 및 이를 포함하는 제약 조성물 Download PDF

Info

Publication number
KR100533565B1
KR100533565B1 KR10-2000-7007850A KR20007007850A KR100533565B1 KR 100533565 B1 KR100533565 B1 KR 100533565B1 KR 20007007850 A KR20007007850 A KR 20007007850A KR 100533565 B1 KR100533565 B1 KR 100533565B1
Authority
KR
South Korea
Prior art keywords
methyl
tri
sulfo
glucopyranosyl
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR10-2000-7007850A
Other languages
English (en)
Korean (ko)
Other versions
KR20010034205A (ko
Inventor
모리스 페티투
Original Assignee
사노피-아벤티스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 사노피-아벤티스 filed Critical 사노피-아벤티스
Publication of KR20010034205A publication Critical patent/KR20010034205A/ko
Application granted granted Critical
Publication of KR100533565B1 publication Critical patent/KR100533565B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078Degradation products

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
KR10-2000-7007850A 1998-01-19 1999-01-13 신규한 오당류, 이의 제조방법 및 이를 포함하는 제약 조성물 Expired - Fee Related KR100533565B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9800514A FR2773801B1 (fr) 1998-01-19 1998-01-19 Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant
FR98/00514 1998-01-19
PCT/FR1999/000045 WO1999036428A1 (fr) 1998-01-19 1999-01-13 Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
KR20010034205A KR20010034205A (ko) 2001-04-25
KR100533565B1 true KR100533565B1 (ko) 2005-12-06

Family

ID=9521913

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2000-7007850A Expired - Fee Related KR100533565B1 (ko) 1998-01-19 1999-01-13 신규한 오당류, 이의 제조방법 및 이를 포함하는 제약 조성물

Country Status (38)

Country Link
US (1) US6670338B1 (https=)
EP (1) EP1049706B1 (https=)
JP (1) JP4695756B2 (https=)
KR (1) KR100533565B1 (https=)
CN (1) CN1172948C (https=)
AR (1) AR012779A1 (https=)
AT (1) ATE241637T1 (https=)
AU (1) AU744137B2 (https=)
BR (1) BR9907100B1 (https=)
CA (1) CA2318326C (https=)
CO (1) CO4970823A1 (https=)
CZ (1) CZ299817B6 (https=)
DE (1) DE69908298T2 (https=)
DK (1) DK1049706T3 (https=)
DZ (1) DZ2706A1 (https=)
EE (1) EE04194B1 (https=)
EG (1) EG23760A (https=)
ES (1) ES2200494T3 (https=)
FR (1) FR2773801B1 (https=)
GT (1) GT199900006A (https=)
HR (1) HRP20000479A8 (https=)
HU (1) HU228335B1 (https=)
IL (2) IL137240A0 (https=)
MY (1) MY125636A (https=)
NO (1) NO316894B1 (https=)
NZ (1) NZ505614A (https=)
PL (1) PL191098B1 (https=)
PT (1) PT1049706E (https=)
RU (1) RU2193040C2 (https=)
SA (1) SA99191114B1 (https=)
SI (1) SI1049706T1 (https=)
SK (1) SK284176B6 (https=)
TR (1) TR200002077T2 (https=)
TW (1) TW550267B (https=)
UA (1) UA61124C2 (https=)
UY (1) UY25357A1 (https=)
WO (1) WO1999036428A1 (https=)
ZA (1) ZA99357B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
AU2003302238A1 (en) 2002-12-03 2004-06-23 Axys Pharmaceuticals, Inc. 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
CN103788141B (zh) * 2004-03-04 2016-08-17 普罗吉恩制药有限公司 硫酸化寡聚糖衍生物
CN100338084C (zh) * 2004-07-02 2007-09-19 北京大学 抑制异种器官移植免疫排斥反应的五糖抗原的合成方法
FR2874924B1 (fr) 2004-09-09 2006-12-01 Sanofi Aventis Sa Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique
TWI403334B (zh) * 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
TWI376234B (en) 2005-02-01 2012-11-11 Msd Oss Bv Conjugates of a polypeptide and an oligosaccharide
US20070191306A1 (en) * 2005-08-17 2007-08-16 Bristol-Myers Squibb Company FACTOR Xa INHIBITOR FORMULATION AND METHOD
EP1908768A1 (en) * 2006-10-05 2008-04-09 Endotis Pharma Anticoagulant compounds
WO2009155108A1 (en) 2008-05-30 2009-12-23 Momenta Pharmaceuticals, Inc. Saccharide structures and methods of making and using such structures
US20110150976A1 (en) * 2008-09-10 2011-06-23 Transpharma Medical Ltd. Transdermal delivery of oligosaccharides
CA2777099C (en) * 2009-07-31 2018-03-27 Reliable Biopharmaceutical Corporation Process for preparing fondaparinux sodium and intermediates useful in the synthesis thereof
US8420790B2 (en) 2009-10-30 2013-04-16 Reliable Biopharmaceutical Corporation Efficient and scalable process for the manufacture of Fondaparinux sodium
EP2721044B1 (en) 2011-06-17 2015-11-18 Carbomimetics Synthetic pentasaccharides having short half-life and high activity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300099A1 (en) * 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
EP0454220B1 (en) * 1990-04-23 1993-08-18 Akzo Nobel N.V. Carbohydrate derivatives comprising a trisaccharide unit
IL102758A (en) * 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
FR2704226B1 (fr) * 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
NZ264340A (en) * 1993-09-01 1995-04-27 Akzo Nobel Nv Bisconjugate comprising two saccharides and a spacer, use in pharmaceutical compositions
FR2751334B1 (fr) * 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
WO1999036428A1 (fr) 1999-07-22
ZA99357B (en) 2000-07-19
UY25357A1 (es) 2000-12-29
CA2318326C (en) 2010-07-06
HRP20000479B8 (hr) 2025-09-12
EP1049706B1 (fr) 2003-05-28
BR9907100A (pt) 2000-10-24
UA61124C2 (en) 2003-11-17
HRP20000479A8 (hr) 2025-09-12
SA99191114B1 (ar) 2006-10-11
CO4970823A1 (es) 2000-11-07
CN1293679A (zh) 2001-05-02
AU744137B2 (en) 2002-02-14
AU1974699A (en) 1999-08-02
CN1172948C (zh) 2004-10-27
NO20003661L (no) 2000-09-19
RU2193040C2 (ru) 2002-11-20
HU228335B1 (en) 2013-03-28
EE200000421A (et) 2001-12-17
ATE241637T1 (de) 2003-06-15
JP4695756B2 (ja) 2011-06-08
FR2773801B1 (fr) 2000-05-12
TR200002077T2 (tr) 2000-12-21
BR9907100B1 (pt) 2013-09-03
US6670338B1 (en) 2003-12-30
NZ505614A (en) 2003-02-28
FR2773801A1 (fr) 1999-07-23
PT1049706E (pt) 2003-09-30
DE69908298D1 (de) 2003-07-03
DE69908298T2 (de) 2004-04-01
KR20010034205A (ko) 2001-04-25
ES2200494T3 (es) 2004-03-01
PL341874A1 (en) 2001-05-07
DK1049706T3 (da) 2003-09-29
HUP0102042A3 (en) 2003-07-28
CZ20002636A3 (cs) 2000-11-15
EG23760A (en) 2007-08-08
NO20003661D0 (no) 2000-07-17
PL191098B1 (pl) 2006-03-31
EE04194B1 (et) 2003-12-15
AR012779A1 (es) 2000-11-08
HRP20000479B1 (hr) 2006-04-30
GT199900006A (es) 2000-07-12
SI1049706T1 (en) 2003-12-31
HK1029999A1 (zh) 2001-04-20
NO316894B1 (no) 2004-06-14
DZ2706A1 (fr) 2003-09-01
IL137240A (en) 2007-10-31
EP1049706A1 (fr) 2000-11-08
TW550267B (en) 2003-09-01
CA2318326A1 (en) 1999-07-22
MY125636A (en) 2006-08-30
HUP0102042A1 (hu) 2001-10-28
HRP20000479A2 (en) 2001-02-28
EE200000421A1 (et) 2003-06-16
IL137240A0 (en) 2001-07-24
SK10792000A3 (sk) 2001-01-18
CZ299817B6 (cs) 2008-12-03
JP2002509154A (ja) 2002-03-26
SK284176B6 (sk) 2004-10-05

Similar Documents

Publication Publication Date Title
JP2000500807A (ja) 合成ポリサッカライド、それらの製造法およびそれらを含む医薬組成物
JP3594990B2 (ja) 3−デオキシオリゴ糖、その製造方法およびそれを含有する医薬組成物
KR100533565B1 (ko) 신규한 오당류, 이의 제조방법 및 이를 포함하는 제약 조성물
KR100513196B1 (ko) 합성 폴리사카라이드, 그의 제조 방법 및 그를 함유한제약 조성물
HU226685B1 (en) Carbohydrate derivatives and pharmaceutical compns. contg. them
JP3501813B2 (ja) 合成ポリサッカライド、それらの製造法およびそれらを含む医薬組成物
HK1029999B (en) New pentasaccharides, their methods of production and pharmaceutical compositions containing same
HU227307B1 (en) Intermediates for the preparation of 3-deoxy-oligosaccharides

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

N231 Notification of change of applicant
PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

FPAY Annual fee payment

Payment date: 20121031

Year of fee payment: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

FPAY Annual fee payment

Payment date: 20131101

Year of fee payment: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

FPAY Annual fee payment

Payment date: 20141107

Year of fee payment: 10

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

FPAY Annual fee payment

Payment date: 20151030

Year of fee payment: 11

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 11

FPAY Annual fee payment

Payment date: 20161028

Year of fee payment: 12

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 12

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20171130

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20171130

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000